Stock CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-18 pm EDT 		5-day change 1st Jan Change
227.6 USD -1.10% Intraday chart for Charles River Laboratories International, Inc. -7.66% -3.74%
Apr. 16 Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing CI
Apr. 12 Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278 MT

Chart calendar Charles River Laboratories International, Inc.

fb44ac0.5nOR-LWS7qfaBLyLjizJdE0wYKZQtfA42UxL1w_M81M.vBXUqOTCguS-bti77R2PNghaLP8a2phsrQUxoGm_tDWfJdis-9WL0K8wyw~85cab5d39f91bd9615076d9a8e508fb3

Upcoming events on Charles River Laboratories International, Inc.

2024-05-08 08:00 am Annual General Meeting
2024-05-09 07:00 am Q1 2024 Earnings Release
2024-05-09 08:30 am Q1 2024 Earnings Call
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-02-11 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Charles River Laboratories International, Inc.

2024-04-09 04:30 pm American Association for Cancer Research Meeting - Poster No:6181
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Poster No:5467
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Poster No:5315
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:4703
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:4413
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:4224
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:4191
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:4186
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:4182
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:3975
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Poster No:2841
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Poster No:2840
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Poster No:2835
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Poster No:2714
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Poster No:2630
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Poster No:2053
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Poster No:2020
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Poster No:1453
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Poster No:1335
2024-04-07 04:30 pm American Association for Cancer Research Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2 621
2 614
0.28%		2 924
2 891
1.15%		3 540
3 522
0.52%		3 976
3 915
1.56%		4 129
4 107
0.54%
4 223

EBITDA
Million USD		Released
Forecast
Spread 		604
597
1.28%		701
693
1.26%		879
878
0.22%		991
982
0.87%		1 013
1 017
-0.4%
1 063

EBIT
Million USD		Released
Forecast
Spread 		497
489
1.64%		585
575
1.73%		742
738
0.51%		834
820
1.67%		839
842
-0.35%
877

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		304
284
7.16%		447
394
13.45%		481
449
7.01%		623
568
9.63%		581
513
13.41%
552

Net income
Million USD		Released
Forecast
Spread 		252
240
4.84%		364
296
23%		391
358
9.2%		486
409
18.85%		475
387
22.66%
420

EPS
USD		Released
Forecast
Spread 		5,07
4,85
4.57%		7,20
5,88
22.44%		7,60
6,99
8.67%		9,48
7,97
18.98%		9,22
7,49
23.07%
8,10

Announcement Date11/02/2017/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		905
888
1.89%		914
909
0.58%		973
995
-2.22%		989
970
1.93%		1 100
1 035
6.26%		1 029
986
4.39%		1 060
1 054
0.59%		1 027
1 000
2.61%		1 013
991
2.24%
993


1 042


1 075


1 113


1 068

EBITDA
Million USD		Released
Forecast
Spread 		227
227
-0.22%		233
233
0.02%		250
247
1.36%		240
238
1.14%		267
260
2.72%		260
252
3.03%		260
258
0.62%		255
241
5.8%		239
242
-1.38%
222


258


283


300


245

EBIT
Million USD		Released
Forecast
Spread 		189
184
2.52%		196
194
1.26%		212
208
1.97%		201
197
2.26%		225
213
5.33%		218
209
3.98%		216
213
1.41%		211
194
8.51%		194
196
-1%
178


212


236


251


203

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		164
135
21.45%		111
149
-25.64%		144
142
1.83%		123
128
-3.67%		245
155
57.85%		131
150
-12.47%		129
143
-10.32%		113
120
-6.11%		209
120
74.62%
96,5


130


157


173


145

Net income
Million USD		Released
Forecast
Spread 		138
109
26.5%		93,0
109
-14.63%		109
110
-0.34%		96,5
98,4
-1.95%		187
109
71.19%		103
102
0.7%		97,0
105
-7.26%		87,4
88,9
-1.74%		187
92,4
102.53%
71,3


99,9


120


132


103

EPS
USD		Released
Forecast
Spread 		2,67
2,03
31.32%		1,81
2,07
-12.39%		2,13
2,13
-0.04%		1,88
1,84
2.12%		3,65
2,14
70.86%		2,01
1,99
0.87%		1,89
2,04
-7.23%		1,69
1,68
0.51%		3,62
1,78
103.94%
1,35


1,92


2,30


2,52


1,96

Announcement Date16/02/2204/05/2203/08/2202/11/2222/02/2311/05/2309/08/2308/11/2314/02/24-----

Upcoming sector events for Charles River Laboratories International, Inc.

2024-04-21 MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-22 SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release
2024-04-23 SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release
2024-04-23 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected)
2024-04-23 CUREVAC N.V.: Q4 2023 Earnings Release (Projected)
2024-04-23 ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release
2024-04-23 EVOTEC SE: Q4 2023 Earnings Release
2024-04-24 01:45 am ADDLIFE AB: Q1 2024 Earnings Release
More events

Past sector events for Charles River Laboratories International, Inc.

2024-04-17 HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release
2024-04-17 02:07 am TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report
2024-04-10 04:10 pm PHARVARIS N.V.: Q4 2023 Earnings Release
2024-04-10 01:22 am POLARIS GROUP: March 2024 Sales and Revenue Release
2024-04-02 02:30 am ABIVAX: Q4 2023 Earnings Release
2024-04-01 09:00 am BIOMEA FUSION, INC.: Q4 2023 Earnings Release
2024-03-28 10:42 pm ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release
2024-03-28 04:28 pm CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release
2024-03-28 04:05 pm ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release
2024-03-28 07:10 am HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. Calendar Charles River Laboratories International, Inc.